2
Winter, waves and Walt Disney / From BER to Fort Lauderdale/Florida with NORSE
more
Stories from Orlando, Florida
- Language:
- Media:
- Period:
- Period:Total
Hearing loss company Acousia Therapeutics to present data for lead candidates ACOU085 & ACOU082 at ARO 2023 MidWinter Meeting February 11–15
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, and its partners from the Translational Hearing Research Group at the Tübingen Hearing Research Center (Department of Otolaryngology, Head and Neck Surgery, University of Tübingen), will present data on its lead candidates — clinical stage ACOU085 and late ...
moreTechnische Universität München
Singapore: A simulation modelling an entire city state
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Tel.: +49 89 289 18198 - E-Mail: presse@tum.de - Web: www.tum.de This news release online: http://go.mytum.de/472224 Pictures for editorial use: http://go.mytum.de/252638 ; http://go.mytum.de/006803 ; http://go.mytum.de/023980 ; http://go.mytum.de/817299 NEWS RELEASE How TUMCREATE takes scientific knowledge from the lab to the real world in Singapore A ...
more- 2
Spirit Airlines Partners up with Materna IPS to Revolutionize DFW with new Self-Bag Drop Installation to Streamline Travel Experience
more - 2
Denver International Airport (DEN) opens the United States’ largest Self-Bag Drop (SBD) installation in cooperation with Materna IPS, United Airlines, and Southwest Airlines
more - 5
OPTIMA is back at the US trade shows
One documentmore UCB Presents Final Results from Phase II Study of Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) at 2019 ASH Annual Meeting
Brussels (ots/PRNewswire) - - Phase II data demonstrate that rozanolixizumab was well tolerated by patients with primary ITP across all dose groups - Clinically relevant improvements in platelet count and decrease in immunoglobin G (IgG) levels were observed in all dose groups - Safety, tolerability and efficacy ...
moreRaytion Announces the Availability of 45+ Microsoft Graph Connectors for Microsoft Search
Orlando, USA, and Düsseldorf, Germany (ots) - Raytion, an internationally operating IT business consultancy and specialist in search-based solutions and content integration, announces the availability of its Microsoft Graph connectors for Microsoft Search. Raytion's connectors integrate more than 45 on-premises and cloud content sources into Microsoft Search. Among ...
moreCaligari Film- und Fernsehproduktions GmbH
New German TV Series "PAN TAU" Features Comedy Magician Matt Edwards
moreLeading Microsoft gold competency partner to spotlight key solutions, differentiated innovation, and industry specializations on Azure
Warren, New Jersey and Bangalore, India (ots/PRNewswire) - Mindtree, a global technology services and digital transformation company, announced that it will showcase its next-generation Microsoft Azure solutions and services at Microsoft Ignite 2019, taking place Nov. 4-8 in Orlando, FL. Recognized as a 'Top ...
moreSYNTAX showcases SAP portfolio at Sapphire Now at booth 1940
Montreal/Weinheim (ots) - - Global IT service provider makes first appearance in the SAP community following acquisition of FIT - Migration, cloud, and security solutions are highlighted The global IT provider SYNTAX exhibits at this year's Sapphire Now SAP conference and the ASUG Annual Conference, which currently takes place in Orlando, Florida. With the acquisition of the global IT service provider FIT (Freudenberg IT) ...
moreNTT DATA Business Solutions AG
itelligence project wins SAP Innovation Award in "Process Innovator" category / Innovative Environmental Protection Project of itelligence AG Honored by SAP
Orlando/Bielefeld (ots) - itelligence has won an SAP Innovation Award in the "Process Innovator" category with a project involving the use of drones and image recognition for the purposes of environmental protection. These awards honor companies that operate successfully in the digital economy making use of SAP ...
moreNTT DATA Business Solutions AG
itelligence Receives 2019 SAP® Pinnacle Award: SAP Global Platinum Reseller of the Year
moreNTT DATA Business Solutions AG
NTT Group Brings Award-Winning Teams, Advanced Technology and Customer Focus to SAP SAPPHIRE NOW®
New York City (ots) - Two Prestigious Awards and 27 Sessions Underscore SAP Expertise and Success Meet NTT Group's family of integrated brands - NTT Communications, Dimension Data, NTT DATA, NTT Advanced Technology, everis, Secure-24 and itelligence - at Booth #421 NTT Group, represented by NTT Communications, ...
moreTresiba® Demonstrated Significantly Improved Blood Sugar Control and Lower Rates of Hypoglycaemia Versus Insulin Glargine U300 in Real-World Evidence Study
Orlando, Florida (ots/PRNewswire) - Adults with type 2 diabetes treated with Tresiba® (insulin degludec injection) had a significant reduction in HbA1c and a 30% lower rate of hypoglycaemic episodes after starting basal insulin Findings from CONFIRM - a large real-world evidence (RWE) study comparing the ...
moreOzempic® Provided Greater Weight Reductions for Adults With a Baseline BMI >=25kg/m2 Than Those With Lower Baseline BMI <25kg/m2, in a SUSTAIN 7 Post-hoc Analysis
Orlando, Florida (ots/PRNewswire) - Poster Presentation #1083-P Ozempic® (semaglutide) 0.5 mg or 1.0 mg provided greater weight reductions vs dulaglutide 0.75 mg or 1.5 mg, respectively, in adults with type 2 diabetes, regardless of baseline body mass index (BMI), with the greatest reductions occurring in adults ...
moreOral Semaglutide Demonstrated Significant Reduction in Blood Sugar vs Placebo in PIONEER 1 Trial
Orlando, Florida (ots/PRNewswire) - Oral semaglutide, an investigational GLP-1 analogue taken as a once-daily tablet, achieved significant reductions in blood sugar versus placebo in adults with type 2 diabetes, according to findings from the PIONEER 1 phase 3a trial. The trial evaluated the efficacy and safety of ...
moreOnce-weekly Semaglutide Demonstrated Consistent Blood Glucose Reductions and Weight Loss Regardless of Background Oral Antidiabetic Treatment
Orlando, Florida (ots/PRNewswire) - Abstract #620 Findings from a post hoc analysis of the phase 3a SUSTAIN 2-4 trials demonstrated greater mean reductions in HbA1c and body weight with once-weekly semaglutide treatment compared to sitagliptin, exenatide extended release (ER) and insulin glargine U100 in adults with ...
moreSemaglutide Demonstrated Superior Glycaemic Control vs Insulin Glargine U100 in Adults with Type 2 Diabetes
Orlando, Florida (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Abstract #290 Findings from a phase 3a clinical trial for semaglutide, an investigational glucagon-like peptide-1 (GLP-1) analogue, demonstrated that treatment ...
more
1